ArticleRenal failure2025
The relationship between estimated pulse wave velocity and 28-day mortality in patients with acute kidney injury combined with congestive heart failure: a retrospective cohort analysis of the MIMIC-IV database.
Article in Renal failure, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between ePWV and delirium risk in icu sepsis patients: a retrospective analysis based on the MIMIC database and development of a predictive model.Clinics (Sao Paulo, Brazil) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundEstimated pulse wave velocity (ePWV) is considered a standalone predictor of mortality in acute kidney injury (AKI) patients throughout their hospitalization. As ePWV increases, the all-cause mortality of heart failure patients increases. This research aimed to explore the connection between ePWV and 28-day mortality among patients diagnosed with AKI alongside congestive heart failure (CHF).
methodsThis study includes 12,119 patients with AKI combined with CHF from the MIMIC-IV database. The ePWV was categorized into a high group (>11.355 m/s) and a low group (≤11.355 m/s) based on the ROC curve cutoff value. To elucidate the discrepancy of survival outcomes between the groups, a Kaplan-Meier survival analysis was conducted. Cox proportional hazards regression models were used to analyze the interplay between ePWV and the risk of mortality within 28 days for the patients. To delve into the dose-response relationship, restricted cubic spline (RCS) model was employed. Stratified analyses were carried out to assess the influence of varying ePWV levels on 28-day mortality across diverse subpopulations.
resultsSurvival analysis reveals that patients exhibiting high ePWV demonstrate a significantly reduced survival rate of 28-day in comparison to those with low ePWV. Moreover, after adjusting for covariates, a strong correlation exists between high ePWV and an increased risk of mortality within 28 days (HR = 1.87,95% CI = 1.68-2.08,
conclusionePWV was significantly associated with 28-day risk of death in patients with AKI-CHF and was a standalone forecasting factor of it.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.